drugset / Trial / NCT06412471
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study includes two parts, part A is for non-squamous NSCLC and part B is for squamous NSCLC.
Timeline
- Start
- 2024-07-26
- Primary completion
- 2025-07
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-08634404 | Unknown | — | — |
| Background | Carboplatin | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |
| Background | Pemetrexed | Small molecule | — | — |
Indications
No indication recorded.